Similar Articles
921 Interplay between microRNA-17-5p, insulin-like growth factor-II through binding protein-3 in hepatocellular carcinoma
922 Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription
923 Metastatic recurrence to a solitary lymph node four years after hepatic lobectomy for primary hepatocellular carcinoma
924 Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms
925 Cancer-associated fibroblasts in hepatocellular carcinoma
926 Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis
927 Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects
928 Progress in systemic therapy of advanced hepatocellular carcinoma
929 Specific CD8+ T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis
930 Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA